Home
»
Meeting Coverage
»
ASRS 2023: Retinal Vascular Disease
CONTRIBUTE
SUBSCRIBE TO NEWSLETTERS
SPECIALTIES
Back
Allergy & Immunology
Cardiology
Critical Care
Dermatology
Endocrinology
Gastroenterology
Infectious Disease
Nephrology
Neurology
OB/GYN
Oncology / Hematology
Ophthalmology
Pain
Pediatrics
Primary Care
Psychiatry
Pulmonology
Rheumatology
Surgery
Urology
Meeting Coverage
DEEP DIVES
Back
Condition Spotlights
Case Consult
inDEPTH Perspectives
Peer-to-Peer
Doctor's Voice
Business of Medicine
CME/CE
MEDIA & RESOURCES
Back
Podcast
Cartoons
SUBSCRIBE TO NEWSLETTERS
CONTRIBUTE
Follow Us
Search
Advertisement
Home
»
Meeting Coverage
»
ASRS 2023: Retinal Vascular Disease
ASRS 2023: Retinal Vascular Disease
Highlights From ASRS - Retinal Vascular Disease
Oct 23, 2023
...
Think You Know the Latest from ASRS on Retinal Vascular Disease?
Oct 12, 2023
Aflibercept 8 mg Provides Vision Gains With Fewer Injections in DME
Aug 22, 2023
Racial & Ethnic Diversity Lacking in Diabetic Retinopathy Trials
Aug 21, 2023
Aflibercept 8 mg Provides “Greater Therapeutic Benefit” in Neovascular AMD
Aug 08, 2023
View More
Advertisement
For latest news and updates
Email-id is invalid